Commission Implementing Decision (EU) 2017/810 of 10 May 2017 on a derogation from mutual recognition of the authorisation of a biocidal product containing boric acid by France in accordance with Article 37 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2017) 2935)

• CELEX: Implementing Decision (EU) 2017/810
• Articles: 2

Article 1

1.   The derogation from mutual recognition proposed by France for the product referred to in paragraph 2 is justified on the grounds of the protection of health and life of humans, particularly of vulnerable groups, as referred to in Article 37(1)(c) of Regulation (EU) No 528/2012.

2.   Paragraph 1 applies to the product identified by the following case number, as provided for by the Register for Biocidal Products:

BC-QC011565-51.

Article 2

This Decision is addressed to the Republic of France.